Showing results (921-930 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 16, 2023
Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca AlkaloidsNima Zafari, Mahla Velayati, Mina Maftooh, et al.Current Pharmaceutical Design|May 16, 2023
Moxifloxacin: Physical-chemical and Microbiological Analytical Methods in the Context of Green Analytical ChemistryThaisa Alves Celedonio da Silva, Isadora Alves Lustosa, Ana Carolina KogawaCurrent Pharmaceutical Design|February 7, 2003
Role of DAP12 in innate and adaptive immune responsesNaoko Aoki, Shoji Kimura, Zhou XingCurrent Pharmaceutical Design|February 7, 2003
Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonistsGerasimos Filippatos, Bruce D UhalCurrent Pharmaceutical Design|February 7, 2003
Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigen-presenting cellAlexis M KalergisCurrent Pharmaceutical Design|February 7, 2003
Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis therapyOrhan Aktas, Frauke ZippCurrent Pharmaceutical Design|February 7, 2003
Re-evaluation of fibrogenic cytokines in lung fibrosisMargaret Kelly, Martin Kolb, Phillipe Bonniaud, et al.Current Pharmaceutical Design|February 7, 2003
Cytokine therapeutics for the treatment of sepsis: why has nothing worked?Daniel G RemickCurrent Pharmaceutical Design|February 7, 2003
The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brainTomas de PaulisCurrent Pharmaceutical Design|February 7, 2003
Calcium as a molecular target in angiogenesisAngela M Patton, Jareer Kassis, Howard Doong, et al.Pageof 1,008